Problem with recombinant protein expression

In summary, a recombinant protein expressed in yeast is low in level, and it is possible that the transcription of the small peptide influences the transcription of the protein of interest. More details about the expresssion vector and the origin of the protein could help. Without more information it is not possible to say for sure whether the small peptide gets transcribed preferentially or not. The tag for the protein purification might be located somewhere in the vicinity of the second coding region.
  • #1
soundlover
6
0
hello all,

a friend of mine has built a plasmid to express a recombinant protein in yeast, but she´s having problems in expressing the protein, the level of expressed protein being to low. i do not recall what is the vector used, the promoter is Gal4.

after that result, she re-analyzed the sequence and discovered that immediately before the ATG of the insert (~10 base pairs before], there is another coding region (~50 bp) that is in frame, and is encoding a small peptide.

something like this:GAL4------ATG--non desired protein-TAG---10bp--ATG-INSERT-TAGthe question now is: it is possible that the transcription of the small peptide influence the transcription of the protein of interest?and the distance between the two coding regions, does it matters?

tks in advance
 
Last edited:
Biology news on Phys.org
  • #2
probably this should be in the chemistry section. my bad
 
  • #3
I don't have much experience with recombinant proteins, but did she check whether the short form is actually expressed? (isolate cDNA).
 
  • #4
Monique said:
I don't have much experience with recombinant proteins, but did she check whether the short form is actually expressed? (isolate cDNA).

no

i updated the initial post with:

and the distance between the two coding regions, does it matters?
 
  • #5
Having more details about the expresssion vector and the origin of the protein could help.
 
  • #6
As mentioned, more info is needed to give a definite answer. In principle it is possible that the smaller peptide gets transcribed preferentially. Also you were talking about low yield.
Is the measured protein really the one in question? That is, have you analyzed the protein sequence (e.g. with MS/MS)?
On a different note, there are gazillions of possibilities why overexpression of proteins fail, including the fact that it may disrupt normal cellular function.
 
  • #7
In eukaryotes, the ribosome generally scans from the 5' end of the messenger RNA to find the first start codon (ATG) and initiates translation from there (in contrast, prokaryotic translation initiation is directed by specific sequences on the mRNA). So, the first ORF is likely being translated and the gene of interest is not.
 
  • #8
Hmm I am not sure what you mean that prokaryotic translation is initiated by specific sequences. Do you mean Shine-Delgarno sequences?
To clarify, maybe. The main difference is that prokaryotic genes are often organized in operons, resulting in transcripts that possesses several genes, often (but not always) carrying individual Shine-Delgarno sequencces.
Eukaryotes generally do not possesses operons (though yeast is a little special in this regard). The transcriptional start is defined upstream of the aug by the Kozak sequence. So, in case there is a complete transcript, which includes both ORF (can easily tested by RT-PCR), there will only one Kosak sequenece, so chances are that the first ORF will be translated preferentially. But as the sequence is so short, there is a fair chance that the second will also be translated. That is why I was asking how the measured protein looks like. Also the question is where the tag (if any) for the protein purification is located.
 

FAQ: Problem with recombinant protein expression

What is recombinant protein expression?

Recombinant protein expression is the process of using genetic engineering techniques to produce large quantities of a specific protein in a host organism, typically a bacterial or mammalian cell. This allows for the production of proteins that are not naturally found in the host organism, which can have various applications in research and medicine.

What are some common challenges with recombinant protein expression?

Some common challenges with recombinant protein expression include low protein yields, protein misfolding or aggregation, and difficulties in purifying the protein. These issues can be caused by various factors such as codon usage, protein toxicity to the host cell, and improper folding or post-translational modifications.

How can I optimize recombinant protein expression?

There are several strategies for optimizing recombinant protein expression, including choosing an appropriate host organism, selecting a suitable expression vector, optimizing codon usage, and using fusion tags or chaperone proteins to assist in folding and purification. Conducting thorough optimization experiments and considering the specific characteristics of the protein can also help improve expression.

What is the role of promoters in recombinant protein expression?

Promoters are DNA sequences that control the expression of a gene by binding to transcription factors. In recombinant protein expression, the choice of promoter can greatly impact the levels of protein production. Strong promoters can lead to high protein yields, but may also cause protein toxicity to the host cell. Weaker promoters may result in lower protein expression, but can be more suitable for producing complex or toxic proteins.

What are some alternative methods for recombinant protein expression?

While the most commonly used method for recombinant protein expression is in vivo expression in a host organism, there are also alternative methods such as in vitro expression using cell-free systems or chemical synthesis. These methods can offer advantages such as faster production times and the ability to produce proteins that are difficult to express in vivo, but may also have limitations in terms of protein folding and modifications.

Similar threads

Back
Top